Cirrus Earplugs Looks To OTC Sleep Aids For Partnership
This article was originally published in The Tan Sheet
Executive Summary
After becoming the leading seller of brand and private-label earplugs, Cirrus Healthcare Products’ further growth depends on expanding the market for its products. CEO Drew O’Connell says he is talking with OTC firms about co-marketing products, with OTC sleep aids as good potential candidates.
You may also be interested in...
P&G Launches ZzzQuil To Enter OTC Sleep Aid Category
While other national brand names compete in the OTC sleep aid tablet category, P&G’s NyQuil line extension is by far the biggest name among current players in the liquid product category, which has annual growth of nearly 80%.
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”